+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
Ocular Drug Delivery Global Market Report 2024 - Product Thumbnail Image

Ocular Drug Delivery Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • November 2024
  • 78 Pages
  • Global
From
Epithelial Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
HER2 Antibodies - Global Strategic Business Report - Product Thumbnail Image

HER2 Antibodies - Global Strategic Business Report

  • Report
  • November 2024
  • 197 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 180 Pages
  • Global
From
From
Loading Indicator